Home›Research›Compare›Humanin vs NAD+
Peptide ComparisonHumanin vs NAD+
Both are Longevity & Cellular peptides.
Humanin
HN
Half-life: ~2-4 hours
13 providers listed
NAD+
NAD
Half-life: ~1–2 hours (IV); variable (oral)
509 providers listed
NAD+ carries stronger published evidence (RCT, 4 key studies) than Humanin (Animal, 5); both are research compounds.
Humanin
Half-life
~2-4 hours
NAD+
Half-life
~1–2 hours (IV); variable (oral)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | NAD+ |
| Less frequent dosing (longer half-life) | Humanin |
| Oral administration option | NAD+ |
| Lower typical price per mg | NAD+ |
| More provider options (13 vs 509) | NAD+ |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Humanin
NAD+
Humanin
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
Humanin improved the rotenone-induced reactive oxygen species formation in PC12 cells by modulating the SIRT3…
Humanin Restores Metabolic Hormone Homeostasis of Leptin, Ghrelin, Irisin and Asprosin in Streptozotocin-Indu…
Neuroprotective Effect of Intraperitoneal Humanin-G in Retinal Degeneration of Royal College of Surgeons Rats.
+1 more
NAD+
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and…
Mitochondrial quality control in human ageing and longevity.
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
About Humanin
Mitochondria-derived peptide; binds gp130 receptor, activates STAT3/JAK pathway; inhibits BAX-mediated apoptosis; improves insulin sensitivity
About NAD+
NAD+ is a coenzyme central to cellular energy metabolism, serving as an electron carrier in glycolysis, the citric acid cycle, and oxidative phosphorylation. It is also a required substrate for sirtuins (SIRT1–7) and PARP enzymes, which regulate DNA repair, gene expression, and mitochondrial biogenesis. NAD+ levels decline measurably with age; IV or subcutaneous delivery aims to restore intracellular pools more directly than oral precursors such as NMN or NR.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Humanin
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
NAD+
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Humanin
NAD+
Where to source these peptides
Humanin
13 listed
Browse directory →
Providers offeringNAD+
509 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated October 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Humanin vs NAD+ — Per-mg Price Comparison. Retrieved October 27, 2026, from https://peptidebase.io/peptides/compare/humanin/nad-plus